4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-051733
Chief Business Development Off sold 417 shares at $45.51 ($18,978)
- Chief Business Development Off acquired 417 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BENZENO SHARON Chief Business Development Off | 2020-09-21 | Option exercise | +417 | $6.27 | $2,615 | 417 | D: show line 1 in the form |
| BENZENO SHARON Chief Business Development Off | 2020-09-21 | Sale | −417 | $45.51 | $18,978 | 0 | D: show line 2 in the form |
| Open-market sales · 417 sh · avg $45.51 · $18,978 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| BENZENO SHARON Chief Business Development Off | 2020-09-21 | Option exercise · Stock Option (Right to Buy) | −417 | 2,917 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…